Product Information
LOXAPINE 5 MG CAPSULE is a generic product labeled by Elite Laboratories, Inc., priced at $0.3092 per EA under NDC 64850089001. Its NADAC has been published 169 times since Jul 12, 2023.
FDA first approved this application on Aug 4, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Elite Laboratories, Inc.NDC
64850089001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LOXAPINE SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA076868FDA Approved
8/4/2005
TE Code
AB
On Market Since
1/27/2020
Price Statistics
The NADAC for LOXAPINE 5 MG CAPSULE has been published 169 times since Jul 12, 2023, and over the history we have for it it has declined 38.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3092 per EA |
|---|---|
| All-time high | $0.5044 (Dec 13, 2023) |
| All-time low | $0.2375 (Jan 22, 2025) |
| 52-week high | $0.3900 |
| 52-week low | $0.2949 |
| Median price | $0.3164 |
| Average price | $0.3457 |
| Largest weekly change | -23.5% (Dec 20, 2023) |
| Weeks tracked | 169 |
| Tracking since | Jul 12, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Elite Laboratories, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Loxapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LOXAPINE 5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LOXAPINE 5 MG CAPSULE, manufactured by Elite Laboratories, Inc., is $0.3092 per EA (NDC 64850089001), effective Sep 30, 2026.
How has the price of LOXAPINE 5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LOXAPINE 5 MG CAPSULE has declined 38.7%. It has been tracked across 169 weekly CMS publications since Jul 12, 2023.
What are the highest and lowest recorded NADAC prices for LOXAPINE 5 MG CAPSULE?
Since Jul 12, 2023, the NADAC for LOXAPINE 5 MG CAPSULE has ranged from a low of $0.2375 (Jan 22, 2025) to a high of $0.5044 (Dec 13, 2023), with a median of $0.3164 per EA.
Are there cheaper alternatives to LOXAPINE 5 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LOXAPINE 5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures LOXAPINE 5 MG CAPSULE?
LOXAPINE 5 MG CAPSULE (NDC 64850089001) is labeled by Elite Laboratories, Inc., and CMS classifies it as a generic product.